1. Home
  2. SPCE vs NYXH Comparison

SPCE vs NYXH Comparison

Compare SPCE & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virgin Galactic Holdings Inc.

SPCE

Virgin Galactic Holdings Inc.

HOLD

Current Price

$3.05

Market Cap

175.5M

ML Signal

HOLD

Logo Nyxoah SA

NYXH

Nyxoah SA

HOLD

Current Price

$3.29

Market Cap

152.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPCE
NYXH
Founded
2017
2009
Country
United States
Belgium
Employees
N/A
N/A
Industry
Transportation Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
175.5M
152.8M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
SPCE
NYXH
Price
$3.05
$3.29
Analyst Decision
Hold
Strong Buy
Analyst Count
5
4
Target Price
$3.26
$11.25
AVG Volume (30 Days)
5.6M
56.6K
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
60.84
N/A
EPS
N/A
N/A
Revenue
$1,544,000.00
N/A
Revenue This Year
$2,766.13
$214.32
Revenue Next Year
$699.18
$124.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.13
$2.76
52 Week High
$5.59
$8.64

Technical Indicators

Market Signals
Indicator
SPCE
NYXH
Relative Strength Index (RSI) 67.41 42.66
Support Level $2.91 $2.76
Resistance Level $3.42 $3.32
Average True Range (ATR) 0.23 0.17
MACD 0.08 0.08
Stochastic Oscillator 77.31 44.32

Price Performance

Historical Comparison
SPCE
NYXH

About SPCE Virgin Galactic Holdings Inc.

Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: